Becton Dickinson said on Wednesday that its Chief Financial Officer Chris DelOrefice will depart the company, effective December 5, after four years at the medical device maker.
Excellergy has emerged with $70 million and an investigative drug class in its portfolio, part of its ambitious mission to ...
The U.S. government has agreed to loan privately-held biotechnology firm Ginkgo Bioworks $1.1 billion for COVID-19 testing and the production of raw materials for therapies that may help address ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback